Clinical Trials Directory

Trials / Completed

CompletedNCT03620812

Influence of Rapeseed Proteins on the Postprandial Metabolic Response

Influence of Rapeseed Proteins on the Postprandial Metabolic Response.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Martin-Luther-Universität Halle-Wittenberg · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate the effect of rapeseed proteins on the postprandial metabolic response. Therefore, study participants will receive a meal rich in fat and carbohydrates with and without rapeseed protein or with soy protein that serves as control.

Detailed description

The current study is a monocentric, controlled intervention study that will be conducted as cross-over design. Three interventions are planned and participants will be invited to consume a test meal with added rapeseed protein isolate, a test meal with added soy protein isolate and a test meal without additional protein. The evening before, the subjects will receive a standardized dinner. After a 12-hour fasting overnight, a cannula will be placed. Blood samples will be taken before and after eating the test meal rich in carbohydrate and fat. The test meal consists of pasta with oily tomato sauce with either 25 g of rapeseed protein, 25 g of soy protein or no additional protein. A total of 11 blood samples will be collected over a period of 6 hours. In the meantime, the blood pressure and pulse will be measured repeatedly and information on satiety will be recorded. The interventions will be interrupted by a period of, at least, 2 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTrapeseed or soy protein or no protein25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day

Timeline

Start date
2018-08-16
Primary completion
2019-04-06
Completion
2019-12-15
First posted
2018-08-08
Last updated
2020-05-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03620812. Inclusion in this directory is not an endorsement.